Bayer has launched Alka-Seltzer in India’s OTC digestive health segment, introducing an antacid with probiotic support to address acidity, gas and indigestion.
Indian pharma companies could soon find a new growth destination in Central Asia as Uzbekistan intensifies efforts to attract foreign investment in its pharmaceutical sector. The country has signaled its willingness to offer additional incentives...
India tightens drug safety norms and mandates pharmacovigilance systems as CDSCO directs pharma firms to strengthen ADR reporting, compliance checks, and post-market safety monitoring.
India's pharma exports to the US are expected to stay muted amid pricing pressure, policy uncertainty, and inventory correction in generics, with experts flagging structural shifts in demand and tighter procurement patterns.
For many couples, the experience of a dream baby comes with lots of queries and concerns. It is common knowledge that fertility treatment is an established procedure that is the same for each individual.
NPPA revises ceiling price of Pfizer’s benzathine benzylpenicillin injection to Rs 13.42 per vial after DoP review, correcting pricing inputs under DPCO guidelines in India.
The Delhi High Court allowing Intas to sell cancer drug Bevatas has emerged as a significant development in India’s pharmaceutical sector, after the court overturned an earlier order that had favoured Sun Pharma in a trademark dispute.
India–Oman CEPA to boost pharma exports with zero-duty access, faster approvals, and reduced compliance, unlocking growth opportunities in Oman’s pharma market.
As India and the United States begin a fresh round of trade negotiations in New Delhi from June 1 to June 4, the pharmaceutical sector has emerged as one of the most closely watched areas of discussion. The talks are expected to focus on tarif...
Zydus Lifesciences gains US FDA priority review for saroglitazar in PBC, strengthening its specialty pipeline amid rising global demand for liver disease therapies.